Baijiayun Group Ltd (RTC)
NASDAQ (NMS) NASDAQ (NMS) Primary 
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial public offering at the top of its target range, putting the clinical-stage neuropsychiatry company on course to raise gross proceeds of $254.9 million. In London, PureTech shareholders saw the share price climb 9.56% to 139.8p.
Puretech gains after FDA meeting post-Phase II trial
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) shares rose 4.9% to 128p on Wednesday after the company said it had completed a successful end-of-Phase 2 meeting with the US Food and Drug Administration for deupirfenidone, its lead idiopathic pulmonary fibrosis candidate. The regulator's feedback supports advancement into a pivotal Phase 3 trial and confirms the suitability of the streamlined 505(b)(2) regulatory pathway, reducing a major point of uncertainty around the programme.
Washoe County's RTC Selects Granite as CMAR for $32M Project
GVA boosts its CAP with a new contract from the RTC of Washoe County as the Construction Manager at Risk.
